Status | Study |
Not yet recruiting |
Study Name: Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid Condition: Melasma Date: 2017-05-11 Interventions: Drug: Modified Jessner's solution |
Completed |
Study Name: A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma Condition: Picoseconds Laser Melasma Date: 2017-02-03 Interventions: Device: Fractional Picosecond 1,064 nm laser |
Completed |
Study Name: Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm Condition: Melasma Date: 2017-01-24 Interventions: Device: PICO+4 picosecond, neo |
Not yet recruiting |
Study Name: 1064-nm Q-switched Nd:YAG Laser and Intradermal Tranexamic Acid for Melasma Condition: Melasma Date: 2016-12-22 Interventions: Procedure: intradermal tranexamic acid |
Recruiting |
Study Name: Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Subjects With Moderate Facial Melasma Condition: Melasma Date: 2016-11-28 Interventions: Other: Lytera 2.0 Lytera 2.0 a |
Not yet recruiting |
Study Name: Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma Condition: Melasma Date: 2016-08-23 Interventions: Drug: 22% TCA peel One of the |
Recruiting |
Study Name: Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma Condition: Melasma Date: 2016-03-29 Interventions: Drug: Illuminate Cream Topical compound applied daily |
Not yet recruiting |
Study Name: Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel Condition: Melasma Date: 2015-10-28 Interventions: Drug: Glycolic acid peel alone |
Completed |
Study Name: A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma Condition: Melasma Date: 2014-04-08 Interventions: Device: Revlite Laser System Revlite Laser System for the Treatment of Melasma |
Completed |
Study Name: Efficacy and Safety of a 4% Hydroquinone Cream (Melanoderm 4%) for the Treatment of Melasma: a Randomized Controlled Split-face Study Condition: Facial Melasma Date: 2014-03-21 Interventions: Drug: Hydroquinone Drug: Placebo |